Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease
暂无分享,去创建一个
John Q. Trojanowski | Bradley T. Hyman | Thomas J. Montine | Yunqi Bu | Xiao-Hua Zhou | Nigel J. Cairns | Walter A. Kukull | Thomas G. Beach | Julie A. Schneider | Peter T. Nelson | Eileen H. Bigio | Harry V. Vinters | Edward B. Lee | J. Schneider | T. Montine | J. Trojanowski | B. Hyman | M. Frosch | N. Cairns | E. Bigio | H. Vinters | W. Kukull | T. Beach | P. Nelson | A. Schantz | Eddie B. Lee | Jonathan C. Henriksen | S. Monsell | J. Sonnen | Xiao-Hua Zhou | Yunqi Bu | J. Kofler | Joshua A. Sonnen | Julia Kofler | Sarah E. Monsell | Matthew Frosch | Jonathan Henriksen | Aimee M. Schantz | J. Schneider | J. Schneider
[1] Ela Patel,et al. Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. , 2012, Journal of neuropathology and experimental neurology.
[2] Jacob Cohen,et al. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. , 1968 .
[3] B. Efron,et al. The Jackknife: The Bootstrap and Other Resampling Plans. , 1983 .
[4] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .
[5] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[6] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[7] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[8] Anil Parwani,et al. Interinstitutional and interstate teleneuropathology , 2011, Journal of pathology informatics.
[9] I. Ferrer,et al. Inter-laboratory comparison of neuropathological assessments of β-amyloid protein: a study of the BrainNet Europe consortium , 2008, Acta Neuropathologica.
[10] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[11] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[12] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[13] C. Wiley,et al. Comparison of telepathology systems in neuropathological intraoperative consultations , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.
[14] B. Efron. The jackknife, the bootstrap, and other resampling plans , 1987 .
[15] I. Ferrer,et al. Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium , 2006, Journal of neuropathology and experimental neurology.
[16] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.